ProShare Advisors LLC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 134 filers reported holding IMMUNITYBIO INC in Q3 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$75,422
-36.2%
44,628
+4.9%
0.00%
Q2 2023$118,283
+69.4%
42,548
+10.9%
0.00%
Q1 2023$69,821
-68.4%
38,363
-12.1%
0.00%
-100.0%
Q4 2022$221,260
+4.4%
43,641
+2.2%
0.00%0.0%
Q3 2022$212,000
+41.3%
42,697
+6.2%
0.00%
Q2 2022$150,000
-50.7%
40,187
-25.8%
0.00%
-100.0%
Q1 2022$304,000
-29.5%
54,191
-23.6%
0.00%0.0%
Q4 2021$431,000
-52.1%
70,910
-23.2%
0.00%
-66.7%
Q3 2021$899,000
-27.1%
92,314
+6.9%
0.00%
-25.0%
Q2 2021$1,233,000
+121.0%
86,331
+267.0%
0.00%
+100.0%
Q1 2021$558,00023,5240.00%
Other shareholders
IMMUNITYBIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
ALLEN HOLDING INC /NY 687,571$4,180,0000.56%
HARBOURVEST PARTNERS LLC 335,709$2,041,0000.26%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$586,0000.20%
SHEETS SMITH WEALTH MANAGEMENT 152,276$926,0000.12%
GSA CAPITAL PARTNERS LLP 129,260$786,0000.10%
Clearwater Capital Advisors, LLC 140,551$855,0000.09%
Virtus ETF Advisers LLC 28,969$176,0000.07%
XTX Topco Ltd 19,159$116,0000.07%
LIBERTY ONE INVESTMENT MANAGEMENT, LLC 49,464$301,0000.04%
Vident Investment Advisory, LLC 168,476$1,024,0000.03%
View complete list of IMMUNITYBIO INC shareholders